MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) was the target of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totaling 13,638 shares, a decrease of 96.0% from the June 30th total of 341,209 shares. Based on an average daily trading volume, of 96,017 shares, the short-interest ratio is presently 0.1 days.
MediPharm Labs Trading Up 0.2%
MediPharm Labs stock traded up $0.00 during mid-day trading on Friday, hitting $0.06. The company’s stock had a trading volume of 100,348 shares, compared to its average volume of 82,309. MediPharm Labs has a 1 year low of $0.04 and a 1 year high of $0.08. The stock’s fifty day moving average is $0.05 and its two-hundred day moving average is $0.05.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
